Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice
    Published on 2026-02-01
    6 months ago
  • Medial prefrontal-thalamic white matter microstructure is associated with harm avoidance in OCD: a discovery and transdiagnostic replication study
    Published on 2026-01-30
    6 months ago
  • Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors
    Published on 2026-01-29
    6 months ago
  • Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive disorders
    Published on 2026-01-29
    6 months ago
  • The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders
    Published on 2026-01-27
    6 months ago
  • The role of ovarian hormones in risk aversion in female rats
    Published on 2026-01-25
    6 months ago
  • Nancy Almand Ator, Ph.D. 1944–2025
    Published on 2026-01-25
    6 months ago
« Previous 1 … 22 23 24 25 26 … 143 Next »
Journal of Psychopharmacology
  • Loss of responsiveness on reinstatement of antidepressants after treatment interruption – A systematic review
    Published on 2025-09-13
    11 months ago
  • Concomitant use of antidepressants and classic psychedelics: A scoping review
    Published on 2025-09-12
    11 months ago
  • Rapid eye movement sleep: Who needs it? Creativity mechanisms and psychiatric applications of REM sleep enhancement
    Published on 2025-09-09
    11 months ago
  • Out of control: Blinding, dose response, and psychosocial controls in psychedelic trials
    Published on 2025-09-01
    11 months ago
  • Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial
    Published on 2025-08-30
    11 months ago
  • Dose-response efficacy and safety of lumateperone in bipolar depression: A preliminary meta-analysis of randomized controlled trials
    Published on 2025-08-28
    11 months ago
  • Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics
    Published on 2025-08-27
    11 months ago
« Previous 1 … 22 23 24 25 26 … 150 Next »
European Neuropsychopharmacology
  • Therapygenetics: Serotonin transporter gene polymorphism (5-HTTLPR) is associated with behavioral treatment response to virtual exposure therapy in patients with spider phobia
    Published on 2025-07-16
    1 year ago
  • Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: findings from the OPTiMiSE trial
    Published on 2025-07-13
    1 year ago
  • Clinical predictors of treatment resistant depression
    Published on 2025-07-12
    1 year ago
  • Inflammation–neurotrophin interplay and depression outcomes: authors’ reply
    Published on 2025-07-12
    1 year ago
  • Genetic variants of uncertain significance in psychiatry and the potential for confusion among patients and clinicians alike
    Published on 2025-07-11
    1 year ago
  • Emotional cognition in patients with borderline personality disorder and patients with bipolar disorder type II: Evidence for transdiagnostic and differential diagnostic differences?
    Published on 2025-07-11
    1 year ago
  • Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens
    Published on 2025-07-11
    1 year ago
« Previous 1 … 22 23 24 25 26 … 168 Next »

   Pharma Pub